These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 7052100)

  • 21. Plasma renin activity in diabetes insipidus.
    Rössler R; Klaus D; Klumpp F
    Ger Med; 1973; 3(3-4):91-2. PubMed ID: 4802902
    [No Abstract]   [Full Text] [Related]  

  • 22. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension.
    van den Born BJ; Koopmans RP; van Montfrans GA
    Am J Hypertens; 2007 Aug; 20(8):900-6. PubMed ID: 17679041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does industrial environment influence the prevalence of arterial hypertension, plasma cholesterol and uric acid concentration and activity of the renin-aldosterone system?
    Wiecek A; Kokot F
    Przegl Lek; 1996; 53(4):356-9. PubMed ID: 8711191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of salt intake on plasma calcitonin gene-related peptide in subjects with mild essential hypertension.
    Zoccali C; Mallamaci F; Parlongo S
    J Hypertens; 1994 Nov; 12(11):1249-53. PubMed ID: 7868872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A comparison of risk factors between silent brain infarction and symptomatic brain infarction--clinical significance of hypertension and diabetes mellitus].
    Kawahata N; Tanaka T
    Rinsho Shinkeigaku; 1995 Oct; 35(10):1114-9. PubMed ID: 8821495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of insulin in hypertension with high and low levels of renin].
    Sindelka G; Widimský J; Prázný M; Kasalová Z; Skrha J
    Cas Lek Cesk; 2001 Apr; 140(7):205-8. PubMed ID: 11374224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of coffee on blood pressure and activity renin-angiotensin- aldosterone system and catecholamines concentration in patients with essential hypertension].
    Mazurek W; Negrusz-Kawecka M
    Pol Merkur Lekarski; 1999 Oct; 7(40):159-63. PubMed ID: 10835904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical evaluation of antihypertensive treatment with alpha-methyldopa in patients with arterial hypertension and diabetes mellitus].
    Stornello M; Di Rao G; Iachello M; Bosco V; Pantano S; Scapellato L
    Clin Ter; 1982 May; 101(3):257-65. PubMed ID: 7094550
    [No Abstract]   [Full Text] [Related]  

  • 31. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.
    Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M
    Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of long-term treatment of arterial hypertension with Ca antagonists on the renin-angiotensin-aldosterone system in diabetics. Hyporeninemic hypoaldosteronism].
    Hrnciar J; Jakubíková K; Hrnciarová M; Kreze A; Chamulová M
    Vnitr Lek; 1995 Oct; 41(10):661-6. PubMed ID: 8578695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relations between renin activity and vascular complications of arterial hypertension].
    Bonfanti F; Pecci R; Nortilli R; Brugnara C; Corrocher R
    Minerva Cardioangiol; 1982 Mar; 30(3):75-80. PubMed ID: 7045721
    [No Abstract]   [Full Text] [Related]  

  • 35. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertension and diabetes: role of the renin-angiotensin system.
    Jandeleit-Dahm K; Cooper ME
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):469-90, vii. PubMed ID: 16959581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Problem of the "hypertension-diabetes" combination. Clinical characteristics and plasma renin activity].
    Pirrelli A; Misceo N; Savino L; Strippoli MC; Stella M; Pieri R
    Boll Soc Ital Cardiol; 1981; 26(7):601-5. PubMed ID: 7052100
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension.
    Uresin Y; Taylor AA; Kilo C; Tschöpe D; Santonastaso M; Ibram G; Fang H; Satlin A
    J Renin Angiotensin Aldosterone Syst; 2007 Dec; 8(4):190-8. PubMed ID: 18205098
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.